Hill R J, Warren M K, Levin J, Gauldie J
Department of Laboratory Medicine, University of California School of Medicine, San Francisco.
Blood. 1992 Jul 15;80(2):346-51.
The induction of thrombocytopenia results in elevated levels of thrombopoietin (TPO), which can be detected in the plasma of experimental animals. Acute, severe thrombocytopenia (platelet count less than 5% of control) was produced in mice by the administration of either guinea pig or rabbit antimouse platelet antiserum. Control mice received equal volumes of normal serum. At various times after the induction of thrombocytopenia (0.5, 1, 2, 3, 4, 6, 12, and 24 hours) citrated plasma was collected, and circulating interleukin-6 (IL-6) levels were measured using the IL-6-dependent murine hybridoma cell line B9. At no time points after induction of thrombocytopenia were plasma IL-6 levels significantly different from control animals that received normal serum. However, injection of heterologous serum did result in slightly elevated plasma IL-6 levels (at 2 and 3 hours) compared with basal levels measured in uninjected animals. This brief increase was not related to the production of thrombocytopenia. Protein fractions from the plasma of thrombocytopenic rabbits were also tested for the presence of IL-6. Preparations that contained TPO, as shown by stimulation of megakaryocyte maturation in vitro, did not contain detectable levels of IL-6. The ability of the B9 assay to detect the elevation of IL-6 levels in murine or rabbit plasma was verified after the administration of bacterial endotoxin, which is known to increase circulating IL-6 concentrations. IL-6 levels were highly elevated in rabbit or mouse serum after the administration of 5 mg/kg or 1 mg/kg of endotoxin, respectively. Anti-IL-6 antiserum did not neutralize the in vitro megakaryocyte maturation activity of partially purified TPO from the plasma of thrombocytopenic rabbits. In addition, IgG purified from the same antiserum did not neutralize partially purified TPO, as shown after incubation with TPO and subsequent precipitation with agarose-bound protein A. These results show that, unlike TPO, levels of IL-6 do not increase after the induction of acute, severe thrombocytopenia, and strongly suggest that IL-6 does not mediate the thrombopoietic response to acute thrombocytopenia. Although prolonged administration of IL-6 has been shown to induce thrombocytosis, IL-6 and TPO are apparently different and immunologically distinct molecules.
血小板减少的诱导会导致血小板生成素(TPO)水平升高,这在实验动物的血浆中可以检测到。通过给予豚鼠或兔抗小鼠血小板抗血清,在小鼠中产生急性、严重血小板减少(血小板计数低于对照的5%)。对照小鼠接受等量的正常血清。在诱导血小板减少后的不同时间点(0.5、1、2、3、4、6、12和24小时)收集枸橼酸化血浆,并使用依赖IL-6的小鼠杂交瘤细胞系B9测量循环白细胞介素-6(IL-6)水平。在诱导血小板减少后的任何时间点,血浆IL-6水平与接受正常血清的对照动物相比均无显著差异。然而,与未注射动物测量的基础水平相比,注射异种血清确实导致血浆IL-6水平略有升高(在2小时和3小时)。这种短暂的升高与血小板减少的产生无关。还对血小板减少兔血浆的蛋白组分进行了IL-6检测。如体外巨核细胞成熟刺激所示,含有TPO的制剂未检测到IL-6水平。在给予已知会增加循环IL-6浓度的细菌内毒素后,验证了B9测定法检测小鼠或兔血浆中IL-6水平升高的能力。分别给予5mg/kg或1mg/kg内毒素后,兔或小鼠血清中的IL-6水平高度升高。抗IL-6抗血清不能中和来自血小板减少兔血浆的部分纯化TPO的体外巨核细胞成熟活性。此外,从同一抗血清中纯化的IgG不能中和部分纯化的TPO,如与TPO孵育后并用琼脂糖结合蛋白A沉淀所示。这些结果表明,与TPO不同,急性、严重血小板减少诱导后IL-6水平不会升高,并强烈提示IL-6不介导对急性血小板减少的血小板生成反应。虽然已表明长期给予IL-6可诱导血小板增多,但IL-6和TPO显然是不同的且在免疫学上有区别的分子。